• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抽动秽语综合征中的5-羟色胺转运体结合

Serotonin transporter binding in Tourette Syndrome.

作者信息

Müller-Vahl Kirsten R, Meyer Geerd J, Knapp Wolfram H, Emrich Hinderk M, Gielow Peter, Brücke Thomas, Berding Georg

机构信息

Department of Clinical Psychiatry and Psychotherapy, Medical School Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Germany.

出版信息

Neurosci Lett. 2005 Sep 9;385(2):120-5. doi: 10.1016/j.neulet.2005.05.031.

DOI:10.1016/j.neulet.2005.05.031
PMID:15936877
Abstract

Recent studies provided evidence for an involvement of the dopaminergic system in the pathophysiology of Tourette Syndrome (TS). However, little is known about possible impairment of other neurotransmitter systems. In obsessive-compulsive disorder (OCD), a common comorbidity in TS, it is suggested that the serotonergic system plays a major role in the pathogenesis. We, therefore, used [I-123]2[beta]-carbomethoxy-3[beta]-(4-iodophenyl)tropane ([123I]beta-CIT) and single photon emission computed tomography (SPECT) to investigate serotonin transporter (SERT) binding capacity in 12 patients with TS with various degrees of associated obsessive compulsive behaviour (OCB) and 16 age-matched healthy controls. Binding ratios in TS patients not receiving serotonin reuptake inhibitors (SSRI) (n=8) were significantly reduced compared to age-adjusted ratios from normal controls (2.8 versus 3.2, p=0.003). Treatment with SSRI resulted in a significant reduction of SERT availability. Performing linear regression analysis for this small group, SSRI-free patients indicated trends for a negative correlation between [123I]beta-CIT binding on SERT and OCB (r=-0.78, p=0.023) as well as complex motor tics (r=-0.68, p=0.064). In healthy controls, but not in the TS group, we found an age-related decline in SERT binding capacity (0.28% decrease per year, p=0.038). Our data are in agreement with previous results suggesting an impairment of the serotonergic system in TS. It can be speculated that the reduction in SERT binding capacity is associated with the degree of comorbid OCB.

摘要

近期研究为多巴胺能系统参与抽动秽语综合征(TS)的病理生理学提供了证据。然而,对于其他神经递质系统可能存在的损害却知之甚少。在TS常见的共病强迫症(OCD)中,有观点认为血清素能系统在发病机制中起主要作用。因此,我们使用[I-123]2β-甲氧羰基-3β-(4-碘苯基)托烷([123I]β-CIT)和单光子发射计算机断层扫描(SPECT),对12例伴有不同程度强迫行为(OCB)的TS患者及16名年龄匹配的健康对照者的血清素转运体(SERT)结合能力进行了研究。未服用血清素再摄取抑制剂(SSRI)的TS患者(n = 8)的结合率与正常对照经年龄校正后的比率相比显著降低(2.8对3.2,p = 0.003)。SSRI治疗导致SERT可用性显著降低。对这个小样本进行线性回归分析时,未服用SSRI的患者显示出[123I]β-CIT在SERT上的结合与OCB(r = -0.78,p = 0.023)以及复杂运动抽动(r = -0.68,p = 0.064)之间呈负相关的趋势。在健康对照者中,而非TS组中,我们发现SERT结合能力存在与年龄相关的下降(每年下降0.28%,p = 0.038)。我们的数据与之前提示TS患者血清素能系统受损的结果一致。可以推测SERT结合能力的降低与共病OCB的程度相关。

相似文献

1
Serotonin transporter binding in Tourette Syndrome.抽动秽语综合征中的5-羟色胺转运体结合
Neurosci Lett. 2005 Sep 9;385(2):120-5. doi: 10.1016/j.neulet.2005.05.031.
2
Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.[123I]β-CIT单光子发射计算机断层扫描显示,未服用过精神药物的强迫症患者多巴胺转运体密度增强。
Am J Psychiatry. 2004 Dec;161(12):2201-6. doi: 10.1176/appi.ajp.161.12.2201.
3
Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.强迫症患者服用氯米帕明期间丘脑-下丘脑5-羟色胺转运体可用性的变化。
Neuropsychopharmacology. 2008 Dec;33(13):3126-34. doi: 10.1038/npp.2008.35. Epub 2008 Mar 19.
4
Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.[(123)I]β-CIT单光子发射计算机断层扫描在人体内活体评估5-羟色胺转运体的验证:一项使用选择性5-羟色胺再摄取抑制剂西酞普兰的双盲、安慰剂对照、交叉研究
Neuropsychopharmacology. 2005 May;30(5):996-1005. doi: 10.1038/sj.npp.1300683.
5
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.强迫症患者大脑中血清素转运体可用性升高。
Biol Psychiatry. 2003 Dec 15;54(12):1406-13. doi: 10.1016/s0006-3223(03)00183-5.
6
Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).强迫症(OCD)中血清素转运体可用性降低。
Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):252-5. doi: 10.1007/s00406-004-0489-y.
7
Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.在使用西酞普兰治疗强迫症一年前后,采用[123I]β-CIT单光子发射计算机断层扫描进行血清素转运体成像。
Neuropsychobiology. 2006;53(1):40-5. doi: 10.1159/000090702. Epub 2006 Jan 4.
8
Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.血清素转运体结合在伴有强迫症的抽动秽语综合征中增加。
Sci Rep. 2019 Jan 30;9(1):972. doi: 10.1038/s41598-018-37710-4.
9
Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.脑内5-羟色胺转运体可用性可预测对选择性5-羟色胺再摄取抑制剂的治疗反应。
Biol Psychiatry. 2004 Oct 1;56(7):497-502. doi: 10.1016/j.biopsych.2004.07.001.
10
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.妥瑞氏症中多巴胺能和血清素能神经传递的机制:来自一项正电子发射断层扫描体内神经化学研究的线索
Neuropsychopharmacology. 2008 May;33(6):1239-51. doi: 10.1038/sj.npp.1301528. Epub 2007 Nov 7.

引用本文的文献

1
Mispatterning and interneuron deficit in Tourette Syndrome basal ganglia organoids.妥瑞氏症基底节类器官中的错配和中间神经元缺失。
Mol Psychiatry. 2022 Dec;27(12):5007-5019. doi: 10.1038/s41380-022-01880-5. Epub 2022 Nov 29.
2
In Silico Analysis Identified Putative Pathogenic Missense nsSNPs in Human Gene.计算机分析鉴定了人类基因中潜在的致病性错义 nsSNP。
Genes (Basel). 2022 Apr 11;13(4):672. doi: 10.3390/genes13040672.
3
Candidate Genes and Pathways Associated with Gilles de la Tourette Syndrome-Where Are We?与妥瑞氏症相关的候选基因和通路——我们进展如何?
Genes (Basel). 2021 Aug 26;12(9):1321. doi: 10.3390/genes12091321.
4
Elevated Expression of Encoding the Serotonin Transporter (SERT) in Gilles de la Tourette Syndrome.血清素转运体(SERT)编码基因在 Gilles de la Tourette 综合征中的高表达。
Genes (Basel). 2021 Jan 12;12(1):86. doi: 10.3390/genes12010086.
5
A Review of the Current Treatment of Tourette Syndrome.抽动秽语综合征当前治疗方法综述
J Pediatr Pharmacol Ther. 2020;25(5):401-412. doi: 10.5863/1551-6776-25.5.401.
6
Serotonin transporter binding is increased in Tourette syndrome with Obsessive Compulsive Disorder.血清素转运体结合在伴有强迫症的抽动秽语综合征中增加。
Sci Rep. 2019 Jan 30;9(1):972. doi: 10.1038/s41598-018-37710-4.
7
Merging the Pathophysiology and Pharmacotherapy of Tics.抽动症的病理生理学与药物治疗的融合
Tremor Other Hyperkinet Mov (N Y). 2019 Jan 9;8:595. doi: 10.7916/D8H14JTX. eCollection 2018.
8
Targeted Re-Sequencing Approach of Candidate Genes Implicates Rare Potentially Functional Variants in Tourette Syndrome Etiology.候选基因的靶向重测序方法揭示了抽动秽语综合征病因中罕见的潜在功能性变异。
Front Neurosci. 2016 Sep 21;10:428. doi: 10.3389/fnins.2016.00428. eCollection 2016.
9
A Review and Update on Tourette Syndrome: Where Is the Field Headed?抽动秽语综合征的研究进展及更新:该领域的未来方向在哪里?
Curr Neurol Neurosci Rep. 2016 Apr;16(4):37. doi: 10.1007/s11910-016-0633-x.
10
Animal models of tic disorders: a translational perspective.抽动障碍的动物模型:转化医学视角
J Neurosci Methods. 2014 Dec 30;238:54-69. doi: 10.1016/j.jneumeth.2014.09.008. Epub 2014 Sep 20.